← Leaderboards
Scott H Donaldson
University Of North Carolina Chapel Hill
$8,054,486
Attributed
$8,054,486
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $680.9K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,054,486 · 12
By mechanism
P01$3,213,433 · 2
P30$2,328,173 · 4
P50$1,803,289 · 1
K08$628,830 · 1
M01$80,761 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Michael R Knowles$33,731,453
- Richard C Boucher$55,332,929
- Wanda K O'Neal$8,008,262
- David B Peden$24,843,616
- Monroe Jackson Stutts$5,415,465
Others in their field
Top investigators on “Cystic Fibrosis”
- John F Engelhardt · University Of Iowa$42,933,706
- Michael R Knowles · University Of North Carolina Chapel Hill$30,250,682
- David A Stoltz · University Of Iowa$25,455,359
- Joseph Zabner · University Of Iowa$25,382,103
- Paul B McCray · University Of Iowa$25,146,293
- Richard C Boucher · University Of North Carolina Chapel Hill$24,890,955
Research focus
Cystic FibrosisSputumMucous Body SubstanceMucociliary ClearanceLungClinical ResearchCystic Fibrosis PatientsExhalationPharmaceutical PreparationsCystic Fibrosis Transmembrane Conductance RegulatorRadionuclide ImagingDrug KineticsLung DiseasesPathogenesisCollectionPropertyPulmonary Cystic FibrosisResearch PersonnelMagnetic Resonance ImagingSamplingOutcome MeasureSalineLeadNovel Therapeutics
Grant awards (38)
Core E: Clinical Translation Core$211,030
P30 · FY2025 · DK · contact PI
Core E: Clinical Translation Core$207,950
P30 · FY2024 · DK · contact PI
Core E: Clinical Translation Core$207,950
P30 · FY2023 · DK · contact PI
Core E: Clinical Translation Core$207,950
P30 · FY2022 · DK · contact PI
Project 3: Treatment of mucostasis and airways obstruction in CF with a novel mucolytic$242,214
P01 · FY2021 · HL · contact PI
Core E: Clinical Translation Core$207,950
P30 · FY2021 · DK · contact PI
Core E: Clinical Translation Core$202,679
P30 · FY2020 · DK · contact PI
Clinical Translation Core$222,270
P30 · FY2019 · DK · contact PI
Project 3: Treatment of mucostasis and airways obstruction in CF with a novel mucolytic$194,628
P01 · FY2019 · HL · contact PI
Project 3: Treatment of mucostasis and airways obstruction in CF with a novel mucolytic$272,128
P01 · FY2018 · HL · contact PI
Clinical Translation Core$222,270
P30 · FY2018 · DK · contact PI
Project 3: Treatment of mucostasis and airways obstruction in CF with a novel mucolytic$272,128
P01 · FY2017 · HL · contact PI
Clinical Translation Core$225,854
P30 · FY2017 · DK · contact PI
Targeting Defective Mucus Clearance in COPD$458,582
P01 · FY2016 · HL · contact PI
Clinical Translation Core$222,270
P30 · FY2016 · DK · contact PI
Targeting Defective Mucus Clearance in COPD$454,189
P01 · FY2015 · HL · contact PI
Clinical Translation Core$190,000
P30 · FY2015 · DK · contact PI
Targeting Defective Mucus Clearance in COPD$450,399
P01 · FY2014 · HL · contact PI
Targeting Defective Mucus Clearance in COPD$423,897
P01 · FY2013 · HL · contact PI
Targeting Defective Mucus Clearance in COPD$445,268
P01 · FY2012 · HL · contact PI
Mucus Dehydration and Evolution of CF Lung Disease$400,396
P50 · FY2010 · HL · contact PI
Mucus Dehydration and Evolution of CF Lung Disease$412,748
P50 · FY2009 · HL · contact PI
Mucus Dehydration and Evolution of CF Lung Disease$397,982
P50 · FY2008 · HL · contact PI
MUCUS CLEARANCE DURING ACUTE EXACERBATIONS OF CYSTIC FIBROSIS$3,367
M01 · FY2008 · RR · contact PI
Mucus Dehydration and Evolution of CF Lung Disease$346,600
P50 · FY2007 · HL · contact PI
Mucus Dehydration and Evolution of CF Lung Disease$245,563
P50 · FY2006 · HL · contact PI
Regulation of ENaC by Serine Proteases in Airways$125,766
K08 · FY2006 · HL · contact PI
COMPREHENSIVE ANALYSIS OF MALNUTRITION IN ADULTS WITH CYSTIC FIBROSIS$2,478
M01 · FY2006 · RR · contact PI
Regulation of ENaC by Serine Proteases in Airways$125,766
K08 · FY2005 · HL
COMPREHENSIVE ANALYSIS OF MALNUTRITION IN ADULTS WITH CYSTIC FIBROSIS$13,194
M01 · FY2005 · RR
EFFICACY OF AMILORIDE AND HYPERTONIC SALINE IN CYSTIC FIBROSIS$6,911
M01 · FY2005 · RR
ORAL SPI-8811 IN PATIENTS WITH CYSTIC FIBROSIS$1,885
M01 · FY2005 · RR
Regulation of ENaC by Serine Proteases in Airways$125,766
K08 · FY2004 · HL
Comprehensive Analysis of Malnutrition in Adults with Cystic Fibrosis$39,906
M01 · FY2004 · RR
Efficacy of Amiloride and Hypertonic Saline in Cystic Fibrosis$8,208
M01 · FY2004 · RR
Oral SPI-8811 in Patients with Cystic Fibrosis$4,812
M01 · FY2004 · RR
Regulation of ENaC by Serine Proteases in Airways$125,766
K08 · FY2003 · HL
Regulation of ENaC by Serine Proteases in Airways$125,766
K08 · FY2002 · HL